Skip to main content
Log in

Modeling thrombin generation: plasma composition based approach

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Thrombin has multiple functions in blood coagulation and its regulation is central to maintaining the balance between hemorrhage and thrombosis. Empirical and computational methods that capture thrombin generation can provide advancements to current clinical screening of the hemostatic balance at the level of the individual. In any individual, procoagulant and anticoagulant factor levels together act to generate a unique coagulation phenotype (net balance) that is reflective of the sum of its developmental, environmental, genetic, nutritional and pharmacological influences. Defining such thrombin phenotypes may provide a means to track disease progression pre-crisis. In this review we briefly describe thrombin function, methods for assessing thrombin dynamics as a phenotypic marker, computationally derived thrombin phenotypes versus determined clinical phenotypes, the boundaries of normal range thrombin generation using plasma composition based approaches and the feasibility of these approaches for predicting risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Raskob GE, Silverstein R, Bratzler DW, Heit JA, White RH (2010) Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop. Am J Prev Med 38:S502–S509

    PubMed  Google Scholar 

  2. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J (2011) Heart disease and stroke statistics–2011 update: a report from the American Heart Association. Circulation 123:e18–e209

    PubMed  Google Scholar 

  3. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd-Jones DM, Nelson SA, Nichol G, Orenstein D, Wilson PW, Woo YJ (2011) Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 123:933–944

    PubMed  Google Scholar 

  4. Mann KG, Orfeo T, Butenas S, Undas A, Brummel-Ziedins K (2009) Blood coagulation dynamics in haemostasis. Hamostaseologie 29:7–16

    CAS  PubMed Central  PubMed  Google Scholar 

  5. Anderson JA, Weitz JI (2010) Hypercoagulable states. Clin Chest Med 31:659–673

    PubMed  Google Scholar 

  6. Heit JA (2007) Thrombophilia: common questions on laboratory assessment and management. Hematology Am Soc Hematol Educ Program 1:127–135

    Google Scholar 

  7. Fraser JS, Gross JD, Krogan NJ (2013) From systems to structure: bridging networks and mechanism. Mol Cell 49:222–231

    CAS  PubMed  Google Scholar 

  8. Chakrabarti A, Miskovic L, Soh KC, Hatzimanikatis V (2013) Towards kinetic modeling of genome-scale metabolic networks without sacrificing stoichiometric, thermodynamic and physiological constraints. Biotechnol J 8:1043–1057

    CAS  PubMed  Google Scholar 

  9. Hockin MF, Jones KC, Everse SJ, Mann KG (2002) A model for the stoichiometric regulation of blood coagulation. J Biol Chem 277:18322–18333

    CAS  PubMed  Google Scholar 

  10. Panteleev MA, Ovanesov MV, Kireev DA, Shibeko AM, Sinauridze EI, Ananyeva NM, Butylin AA, Saenko EL, Ataullakhanov FI (2006) Spatial propagation and localization of blood coagulation are regulated by intrinsic and protein C pathways, respectively. Biophys J 90:1489–1500

    CAS  PubMed Central  PubMed  Google Scholar 

  11. Luan D, Zai M, Varner JD (2007) Computationally derived points of fragility of a human cascade are consistent with current therapeutic strategies. PLoS Comput Biol 3:e142

    PubMed Central  PubMed  Google Scholar 

  12. Anand M, Rajagopal K, Rajagopal KR (2008) A model for the formation, growth, and lysis of clots in quiescent plasma. A comparison between the effects of antithrombin III deficiency and protein C deficiency. J Theor Biol 253:725–738

    CAS  PubMed  Google Scholar 

  13. Chatterjee MS, Denney WS, Jing H, Diamond SL (2010) Systems biology of coagulation initiation: kinetics of thrombin generation in resting and activated human blood. PLoS Comput Biol 6:e1000950

    PubMed Central  PubMed  Google Scholar 

  14. Mitrophanov AY, Reifman J (2011) Kinetic modeling sheds light on the mode of action of recombinant factor VIIa on thrombin generation. Thromb Res 128:381–390

    CAS  PubMed  Google Scholar 

  15. Hall CL, Slack SM, Turitto VT (1998) A computational analysis of FXa generation by TF:FVIIa on the surface of rat vascular smooth muscle cells. Ann Biomed Eng 26:28–36

    CAS  PubMed  Google Scholar 

  16. Kuharsky AL, Fogelson AL (2001) Surface-mediated control of blood coagulation: the role of binding site densities and platelet deposition. Biophys J 80:1050–1074

    CAS  PubMed Central  PubMed  Google Scholar 

  17. Ataullakhanov FI, Panteleev MA (2005) Mathematical modeling and computer simulation in blood coagulation. Pathophysiol Haemost Thromb 34:60–70

    Google Scholar 

  18. Fogelson AL, Tania N (2005) Coagulation under flow: the influence of flow-mediated transport on the initiation and inhibition of coagulation. Pathophysiol Haemost Thromb 34:91–108

    CAS  PubMed  Google Scholar 

  19. Runyon MK, Kastrup CJ, Johnson-Kerner BL, Ha TG, Ismagilov RF (2008) Effects of shear rate on propagation of blood clotting determined using microfluidics and numerical simulations. J Am Chem Soc 130:3458–3464

    CAS  PubMed  Google Scholar 

  20. Xu Z, Christley S, Lioi J, Kim O, Harvey C, Sun W, Rosen ED, Alber M (2012) Multiscale model of fibrin accumulation on the blood clot surface and platelet dynamics. Methods Cell Biol 110:367–388

    PubMed  Google Scholar 

  21. Neeves KB, Illing DA, Diamond SL (2010) Thrombin flux and wall shear rate regulate fibrin fiber deposition state during polymerization under flow. Biophys J 98:1344–1352

    CAS  PubMed Central  PubMed  Google Scholar 

  22. Neeves KB, Onasoga AA, Wufsus AR (2013) The use of microfluidics in hemostasis: clinical diagnostics and biomimetic models of vascular injury. Curr Opin Hematol 20:417–423

    CAS  PubMed  Google Scholar 

  23. Butenas S, Orfeo T, Gissel MT, Brummel KE, Mann KG (2004) The significance of circulating factor IXa in blood. J Biol Chem 279:22875–22882

    CAS  PubMed  Google Scholar 

  24. Bravo MC, Orfeo T, Mann KG, Everse SJ (2012) Modeling of human factor Va inactivation by activated protein C. BMC Syst Biol 6:45

    CAS  PubMed Central  PubMed  Google Scholar 

  25. Brummel-Ziedins KE, Orfeo T, Callas PW, Gissel M, Mann KG, Bovill EG (2012) The prothrombotic phenotypes in familial protein C deficiency are differentiated by computational modeling of thrombin generation. PLoS ONE 7:e44378

    CAS  PubMed Central  PubMed  Google Scholar 

  26. Orfeo T, Butenas S, Brummel-Ziedins KE, Gissel M, Mann KG (2010) Anticoagulation by factor Xa inhibitors. J Thromb Haemost 8:1745–1753

    CAS  PubMed Central  PubMed  Google Scholar 

  27. Brummel-Ziedins KE, Pouliot RL, Mann KG (2004) Thrombin generation: phenotypic quantitation. J Thromb Haemost 2:281–288

    CAS  PubMed  Google Scholar 

  28. Crawley JT, Zanardelli S, Chion CK, Lane DA (2007) The central role of thrombin in hemostasis. J Thromb Haemost 5(Suppl 1):95–101

    CAS  PubMed  Google Scholar 

  29. Hemker HC, Beguin S (2000) Phenotyping the clotting system. Thromb Haemost 84:747–751

    CAS  PubMed  Google Scholar 

  30. Brummel-Ziedins K, Vossen CY, Rosendaal FR, Umezaki K, Mann KG (2005) The plasma hemostatic proteome: thrombin generation in healthy individuals. J Thromb Haemost 3:1472–1481

    CAS  PubMed Central  PubMed  Google Scholar 

  31. Brummel-Ziedins KE, Vossen CY, Butenas S, Mann KG, Rosendaal FR (2005) Thrombin generation profiles in deep venous thrombosis. J Thromb Haemost 3:2497–2505

    CAS  PubMed Central  PubMed  Google Scholar 

  32. Brummel-Ziedins K, Undas A, Orfeo T, Gissel M, Butenas S, Zmudka K, Mann KG (2008) Thrombin generation in acute coronary syndrome and stable coronary artery disease: dependence on plasma factor composition. J Thromb Haemost 6:104–110

    CAS  PubMed  Google Scholar 

  33. Brummel-Ziedins KE, Orfeo T, Rosendaal FR, Undas A, Rivard GE, Butenas S, Mann KG (2009) Empirical and theoretical phenotypic discrimination. J Thromb Haemost 7(Suppl 1):181–186

    CAS  PubMed Central  PubMed  Google Scholar 

  34. Brummel-Ziedins KE, Whelihan MF, Gissel M, Mann KG, Rivard GE (2009) Thrombin generation and bleeding in haemophilia A. Haemophilia 15:1118–1125

    CAS  PubMed Central  PubMed  Google Scholar 

  35. Brummel-Ziedins KE, Orfeo T, Gissel M, Mann KG, Rosendaal FR (2012) Factor Xa generation by computational modeling: an additional discriminator to thrombin generation evaluation. PLoS ONE 7:e29178

    CAS  PubMed Central  PubMed  Google Scholar 

  36. Brummel-Ziedins KE, Lam PH, Gissel M, Gauthier E, Schneider DJ (2013) Depletion of systemic concentrations of coagulation factors in blood from patients with atherosclerotic vascular disease. Coron Artery Dis 24:468–474

    PubMed  Google Scholar 

  37. Baker JV, Brummel-Ziedins K, Neuhaus J, Duprez D, Cummins N, Dalmau D, Dehovitz J, Lehmann C, Sullivan A, Woolley I, Kuller L, Neaton JD, Tracy RP (2013) HIV replication alters the composition of extrinsic pathway coagulation factors and increases thrombin generation. J Am Heart Assoc 2:e000264

    PubMed Central  PubMed  Google Scholar 

  38. Brummel-Ziedins K (2013) Models for thrombin generation and risk of disease. J Thromb Haemost 11(Suppl 1):212–223

    PubMed  Google Scholar 

  39. Mann KG, Brummel K, Butenas S (2003) What is all that thrombin for? J Thromb Haemost 1:1504–1514

    CAS  PubMed  Google Scholar 

  40. Xue J, Wu Q, Westfield LA, Tuley EA, Lu D, Zhang Q, Shim K, Zheng X, Sadler JE (1998) Incomplete embryonic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency in mice. Proc Natl Acad Sci USA 95:7603–7607

    CAS  PubMed  Google Scholar 

  41. Bar-Shavit R, Kahn A, Mudd MS, Wilner GD, Mann KG, Fenton JW 2nd (1984) Localization of a chemotactic domain in human thrombin. Biochemistry 23:397–400

    CAS  PubMed  Google Scholar 

  42. Bar-Shavit R, Kahn AJ, Mann KG, Wilner GD (1986) Identification of a thrombin sequence with growth factor activity on macrophages. Proc Natl Acad Sci USA 83:976–980

    CAS  PubMed  Google Scholar 

  43. Morawitz P (1905) Die chemie der blutgerrinnung. Ergebn Physiol. 4:307

    Google Scholar 

  44. Fuld E, Spiro K (1904) Der einflup einiger gerrinnungshemmender agentien auf das Vogel plasma. Beitr z Chem Phys u Path (Hofmeister’s) 5:171

    CAS  Google Scholar 

  45. Coughlin SR (1999) How the protease thrombin talks to cells. Proc Natl Acad Sci USA 96:11023–11027

    CAS  PubMed  Google Scholar 

  46. Tracy PB (1988) Regulation of thrombin generation at cell surfaces. Semin Thromb Hemost 14:227–233

    CAS  Google Scholar 

  47. Bouchard BA, Tracy PB (2001) Platelet regulation of thrombin generation in cardiovascular disease. Italian Heart J 2:819–823

    CAS  Google Scholar 

  48. Mosesson MW (1992) The roles of fibrinogen and fibrin in hemostasis and thrombosis. Semin Hematol 29:177–188

    CAS  PubMed  Google Scholar 

  49. Spraggon G, Everse SJ, Doolittle RF (1997) Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin. Nature 389:455–462

    CAS  PubMed  Google Scholar 

  50. Hantgan R, McDonagh J, Hermans J (1983) Fibrin assembly. Ann NY Acad Sci 408:344–366

    CAS  PubMed  Google Scholar 

  51. Lorand L, Jeong JM, Radek JT, Wilson J (1993) Human plasma factor XIII: subunit interactions and activation of zymogen. Method Enzymol 222:22–35

    CAS  Google Scholar 

  52. Lorand L, Konishi K (1964) Activation of the fibrin-stabilizing factor of plasma by thrombin. Arch Biochem Biophys 105:58

    CAS  PubMed  Google Scholar 

  53. Yee VC, Pedersen LC, Le TI, Bishop PD, Stenkamp RE, Teller DC (1994) Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII. Proc Natl Acad Sci USA 91:7296–7300

    CAS  PubMed  Google Scholar 

  54. Bajzar L, Manuel R, Nesheim ME (1995) Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. J Biol Chem 270:14477–14484

    CAS  PubMed  Google Scholar 

  55. Bajzar L, Morser J, Nesheim M (1996) TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J Biol Chem 271:16603–16608

    CAS  PubMed  Google Scholar 

  56. Mann KG, Jenny RJ, Krishnaswamy S (1988) Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. Annu Rev Biochem 57:915–956

    CAS  PubMed  Google Scholar 

  57. Fay PJ (1988) Subunit structure of thrombin-activated human factor VIIIa. Biochim Biophys Acta 952:181–190

    CAS  PubMed  Google Scholar 

  58. Jenny RJ, Pittman DD, Toole JJ, Kriz RW, Aldape RA, Hewick RM, Kaufman RJ, Mann KG (1987) Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci USA 84:4846–4850

    CAS  PubMed  Google Scholar 

  59. Lollar P, Parker CG (1989) Subunit structure of thrombin-activated porcine factor VIII. Biochemistry 28:666–674

    CAS  PubMed  Google Scholar 

  60. Radcliffe R, Nemerson Y (1975) Activation and control of factor VII by activated factor X and thrombin. Isolation and characterization of a single chain form of factor VII. J Biol Chem 250:388–395

    CAS  PubMed  Google Scholar 

  61. Esmon CT (1995) Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. FASEB J 9:946–955

    CAS  PubMed  Google Scholar 

  62. Mann KG (2011) Thrombin generation in hemorrhage control and vascular occlusion. Circulation 124:225–235

    PubMed Central  PubMed  Google Scholar 

  63. Esmon CT (2003) The protein C pathway. Chest 124:26S–32S

    CAS  PubMed  Google Scholar 

  64. Kalafatis M, Egan JO (1997) van ‘t Veer C, Cawthern KM, Mann KG. The regulation of clotting factors. Crit Rev Eukaryot Gene Expr 7:241–280

    CAS  PubMed  Google Scholar 

  65. Olson ST, Shore JD (1982) Demonstration of a two-step reaction mechanism for inhibition of alpha-thrombin by antithrombin III and identification of the step affected by heparin. J Biol Chem 257:14891–14895

    CAS  PubMed  Google Scholar 

  66. Parker KA, Tollefsen DM (1985) The protease specificity of heparin cofactor II. Inhibition of thrombin generated during coagulation. J Biol Chem 260:3501–3505

    CAS  PubMed  Google Scholar 

  67. Harpel PC (1970) Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein. J Exp Med 132:329–352

    CAS  PubMed Central  PubMed  Google Scholar 

  68. Brummel KE, Paradis SG, Butenas S, Mann KG (2002) Thrombin functions during tissue factor-induced blood coagulation. Blood 100:148–152

    CAS  PubMed  Google Scholar 

  69. Rand MD, Lock JB, van’t Veer C, Gaffney DP, Mann KG (1996) Blood clotting in minimally altered whole blood. Blood 88:3432–3445

    CAS  PubMed  Google Scholar 

  70. Al Dieri R, Peyvandi F, Santagostino E, Giansily M, Mannucci PM, Schved JF, Beguin S, Hemker HC (2002) The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding. Thromb Haemost 88:576–582

    PubMed  Google Scholar 

  71. Dargaud Y, Beguin S, Lienhart A, Al Dieri R, Trzeciak C, Bordet JC, Hemker HC, Negrier C (2005) Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B. Thromb Haemost 93:475–480

    CAS  PubMed  Google Scholar 

  72. Hemker HC, Giesen P, AlDieri R, Regnault V, de Smed E, Wagenvoord R, Lecompte T, Beguin S (2002) The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 32:249–253

    CAS  PubMed  Google Scholar 

  73. Regnault V, Hemker HC, Wahl D, Lecompte T (2004) Phenotyping the haemostatic system by thrombography—potential for the estimation of thrombotic risk. Thromb Res 114:539–545

    CAS  PubMed  Google Scholar 

  74. Allen GA, Hoffman M, Roberts HR, Monroe DM (2006) Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophilia. Br J Haematol 134:314–319

    CAS  PubMed  Google Scholar 

  75. Allen GA, Persson E, Campbell RA, Ezban M, Hedner U, Wolberg AS (2007) A variant of recombinant factor VIIa with enhanced procoagulant and antifibrinolytic activities in an in vitro model of hemophilia. Arterioscler Thromb Vasc Biol 27:683–689

    CAS  Google Scholar 

  76. Van’t Veer C, Golden NJ, Mann KG (2000) Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa. Blood 95:1330–1335

    Google Scholar 

  77. Butenas S, Brummel KE, Branda RF, Paradis SG, Mann KG (2002) Mechanism of factor VIIa-dependent coagulation in hemophilia blood. Blood 99:923–930

    CAS  PubMed  Google Scholar 

  78. Gissel M, Whelihan MF, Ferris LA, Mann KG, Rivard GE, Brummel-Ziedins KE (2012) The influence of prophylactic factor VIII in severe haemophilia A. Haemophilia 18:193–199

    CAS  PubMed Central  PubMed  Google Scholar 

  79. Cawthern KM, van’t Veer C, Lock JB, DiLorenzo ME, Branda RF, Mann KG (1998) Blood coagulation in hemophilia A and hemophilia C. Blood 91:4581–4592

    CAS  PubMed  Google Scholar 

  80. Brummel-Ziedins KE, Whelihan MF, Rivard GE, Butenas S (2011) Activated protein C inhibitor for correction of thrombin generation in hemophilia A blood and plasma1. J Thromb Haemost 9:2262–2267

    CAS  PubMed  Google Scholar 

  81. Poort SR, Michiels JJ, Reitsma PH, Bertina RM (1994) Homozygosity for a novel missense mutation in the prothrombin gene causing a severe bleeding disorder. Thromb Haemost 72:819–824

    CAS  PubMed  Google Scholar 

  82. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698–3703

    CAS  PubMed  Google Scholar 

  83. Reuner KH, Ruf A, Grau A, Rickmann H, Stolz E, Juttler E, Druschky KF, Patscheke H (1998) Prothrombin gene G20210 ≥ A transition is a risk factor for cerebral venous thrombosis. Stroke 29:1765–1769

    CAS  PubMed  Google Scholar 

  84. Margaglione M, Brancaccio V, Giuliani N, D’Andrea G, Cappucci G, Iannaccone L, Vecchione G, Grandone E, Di Minno G (1998) Increased risk for venous thrombosis in carriers of the prothrombin G ≥ A20210 gene variant. Ann Intern Med 129:89–93

    CAS  PubMed  Google Scholar 

  85. Quick AJ, Stanley-Brown M, Bancroft FW (1935) A study of the coagulation defect in hemophilia and in jaundice. Am J Med Sci 190:501

    Google Scholar 

  86. Owren PA, Aas K (1951) The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand J Clin Lab Invest 3:201–208

    CAS  PubMed  Google Scholar 

  87. Langdell RD, Wagner RH, Brinkhous KM (1953) Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure. J Lab Clin Med 41:637–647

    CAS  PubMed  Google Scholar 

  88. Nair SC, Dargaud Y, Chitlur M, Srivastava A (2010) Tests of global haemostasis and their applications in bleeding disorders. Haemophilia 16(Suppl 5):85–92

    PubMed  Google Scholar 

  89. Young G, Sorensen B, Dargaud Y, Negrier C, Brummel-Ziedins K, Key NS (2013) Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state-of-art and future perspectives. Blood. 121:1944–1950

    CAS  PubMed  Google Scholar 

  90. van Geffen M, van Heerde WL (2012) Global haemostasis assays, from bench to bedside. Thromb Res 129:681–687

    PubMed  Google Scholar 

  91. Hemker HC (2005) Calibrated automated thrombinography (CAT). Thromb Res 115:255

    CAS  PubMed  Google Scholar 

  92. Ninivaggi M, Apitz-Castro R, Dargaud Y, de Laat B, Hemker HC, Lindhout T (2012) Whole-blood thrombin generation monitored with a calibrated automated thrombogram-based assay. Clin Chem 58:1252–1259

    CAS  PubMed  Google Scholar 

  93. Hartert H (1948) Not Available. Klinische Wochenschrift 26:577–583

    CAS  PubMed  Google Scholar 

  94. Lawson JH, Kalafatis M, Stram S, Mann KG (1994) A model for the tissue factor pathway to thrombin. I. An empirical study. J Biol Chem 269:23357–23366

    CAS  PubMed  Google Scholar 

  95. Butenas S, van’t Veer C, Mann KG (1999) Normal thrombin generation. Blood 94:2169–2178

    CAS  PubMed  Google Scholar 

  96. Perzborn E, Roehrig S, Straub A, Kubitza D, Mueck W, Laux V (2010) Rivaroxaban: a new oral factor Xa inhibitor. Arterioscler Thromb Vasc Biol 30:376–381

    CAS  PubMed  Google Scholar 

  97. Foley JH, Orfeo T, Undas A, McLean KC, Bernstein IM, Rivard GE, Mann KG, Everse SJ, Brummel-Ziedins KE (2013) From principle to practice: bridging the gap in patient profiling. PLoS ONE 8:e54728

    CAS  PubMed Central  PubMed  Google Scholar 

  98. Danforth CM, Orfeo T, Everse SJ, Mann KG, Brummel-Ziedins KE (2012) Defining the boundaries of normal thrombin generation: investigations into hemostasis. PLoS ONE 7:e30385

    CAS  PubMed Central  PubMed  Google Scholar 

  99. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, Lecompte T, Beguin S (2003) Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 33:4–15

    CAS  PubMed  Google Scholar 

  100. Dargaud Y, Francillon S, Negrier C (2009) Intraindividual thrombin generation measurement variability in healthy adults over a 1 year period. Thromb Res 124:237–238

    CAS  PubMed  Google Scholar 

  101. Haidl H, Cimenti C, Leschnik B, Zach D, Muntean W (2006) Age-dependency of thrombin generation measured by means of calibrated automated thrombography (CAT). Thromb Haemost 95:772–775

    CAS  PubMed  Google Scholar 

  102. McLean KC, Bernstein IM, Brummel-Ziedins KE (2012) Tissue factor-dependent thrombin generation across pregnancy. Am J Obstet Gynecol 207(135):e1–e6

    PubMed  Google Scholar 

  103. Dargaud Y, Hierso S, Rugeri L, Battie C, Gaucherand P, Negrier C, Trzeciak MC (2010) Endogenous thrombin potential, prothrombin fragment 1 + 2 and d-dimers during pregnancy. Thromb Haemost 103:469–471

    CAS  PubMed  Google Scholar 

  104. Eichinger S, Weltermann A, Philipp K, Hafner E, Kaider A, Kittl EM, Brenner B, Mannhalter C, Lechner K, Kyrle PA (1999) Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden. Thromb Haemost 82:1232–1236

    CAS  PubMed  Google Scholar 

  105. Kjellberg U, Andersson NE, Rosen S, Tengborn L, Hellgren M (1999) APC resistance and other haemostatic variables during pregnancy and puerperium. Thromb Haemost 81:527–531

    CAS  PubMed  Google Scholar 

  106. Curvers J, Thomassen MC, Rimmer J, Hamulyak K, van der Meer J, Tans G, Preston FE, Rosing J (2002) Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test. Thromb Haemost 88:5–11

    CAS  PubMed  Google Scholar 

  107. Rosenkranz A, Hiden M, Leschnik B, Weiss EC, Schlembach D, Lang U, Gallistl S, Muntean W (2008) Calibrated automated thrombin generation in normal uncomplicated pregnancy. Thromb Haemost 99:331–337

    CAS  PubMed  Google Scholar 

  108. Bartsch P, Welsch B, Albert M, Friedmann B, Levi M, Kruithof EK (1995) Balanced activation of coagulation and fibrinolysis after a 2-h triathlon. Med Sci Sports Exerc 27:1465–1470

    CAS  PubMed  Google Scholar 

  109. Weiss C, Seitel G, Bartsch P (1998) Coagulation and fibrinolysis after moderate and very heavy exercise in healthy male subjects. Med Sci Sports Exerc 30:246–251

    CAS  PubMed  Google Scholar 

  110. Weiss C, Velich T, Niebauer J, Hauer K, Kalberer B, Kubler W, Bartsch P (1998) Activation of coagulation and fibrinolysis after rehabilitative exercise in patients with coronary artery disease. Am J Cardiol 81:672–677

    CAS  PubMed  Google Scholar 

  111. Cimenti C, Schlagenhauf A, Leschnik B, Schretter M, Tschakert G, Groschl W, Seibert FJ, Hofmann P, Muntean WE (2013) Low endogenous thrombin potential in trained subjects. Thromb Res 131:e281–e285

    CAS  PubMed  Google Scholar 

  112. Mari D, Mannucci PM, Coppola R, Bottasso B, Bauer KA, Rosenberg RD (1995) Hypercoagulability in centenarians: the paradox of successful aging. Blood 85:3144–3149

    CAS  PubMed  Google Scholar 

  113. Sagripanti A, Carpi A (1998) Natural anticoagulants, aging, and thromboembolism. Exp Gerontol 33:891–896

    CAS  PubMed  Google Scholar 

  114. Holmes VA, Wallace JM (2005) Haemostasis in normal pregnancy: a balancing act? Biochem Soc Trans 33:428–432

    CAS  PubMed  Google Scholar 

  115. Bremme KA (2003) Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 16:153–168

    PubMed  Google Scholar 

  116. O’Donnell J, Mumford AD, Manning RA, Laffan MA (2001) Marked elevation of thrombin generation in patients with elevated FVIII:C and venous thromboembolism. Br J Haematol 115:687–691

    PubMed  Google Scholar 

  117. Tripodi A, Primignani M, Chantarangkul V, Dell’Era A, Clerici M, de Franchis R, Colombo M, Mannucci PM (2009) An imbalance of pro- versus anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology 137:2105–2111

    CAS  PubMed  Google Scholar 

  118. Allen GA, Wolberg AS, Oliver JA, Hoffman M, Roberts HR, Monroe DM (2004) Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system. J Thromb Haemost 2:402–413

    CAS  PubMed  Google Scholar 

  119. Xi M, Beguin S, Hemker HC (1989) The relative importance of the factors II, VII, IX and X for the prothrombinase activity in plasma of orally anticoagulated patients. Thromb Haemost 62:788–791

    CAS  PubMed  Google Scholar 

  120. Brummel-Ziedins KE, Branda RF, Butenas S, Mann KG (2009) Discordant fibrin formation in hemophilia. J Thromb Haemost 7:825–832

    CAS  PubMed Central  PubMed  Google Scholar 

  121. Brummel Ziedins K, Rivard GE, Pouliot RL, Butenas S, Gissel M, Parhami-Seren B, Mann KG (2004) Factor VIIa replacement therapy in factor VII deficiency. J Thromb Haemost 2:1735–1744

    CAS  PubMed  Google Scholar 

  122. Brummel-Ziedins K, Callas PW, Orfeo T, Gissel M, Hockin MF, Mann KG, Bovill EG (2009) Evaluating thrombin generation in a family with protein C deficiency. J Thromb Haemost 7:162–163

    Google Scholar 

  123. Foley JH, Ferris L, Brummel-Ziedins KE (2012) Characteristics of fibrin formation and clot stability in individuals with congenital type IIb protein C deficiency. Thromb Res 129:e142–e146

    CAS  PubMed Central  PubMed  Google Scholar 

  124. Undas A, Jankowski M, Kaczmarek P, Sladek K, Brummel-Ziedins K (2011) Thrombin generation in chronic obstructive pulmonary disease: dependence on plasma factor composition. Thromb Res 128:e24–e28

    CAS  PubMed Central  PubMed  Google Scholar 

  125. Gissel M, Undas A, Slowik A, Mann KG, Brummel-Ziedins KE (2010) Plasma factor and inhibitor composition contributes to thrombin generation dynamics in patients with acute or previous cerebrovascular events. Thromb Res 126:262–269

    CAS  PubMed Central  PubMed  Google Scholar 

  126. Undas A, Gissel M, Kwasny-Krochin B, Gluszko P, Mann KG, Brummel-Ziedins KE (2010) Thrombin generation in rheumatoid arthritis: dependence on plasma factor composition. Thromb Haemost 104:224–230

    CAS  PubMed Central  PubMed  Google Scholar 

  127. Brummel-Ziedins KE, Gissel M, Francis C, Queenan J, Mann KG (2009) The effect of high circulating estradiol levels on thrombin generation during in vitro fertilization. Thromb Res 124:505–507

    CAS  PubMed Central  PubMed  Google Scholar 

  128. Danforth CM, Orfeo T, Mann KG, Brummel-Ziedins KE, Everse SJ (2009) The impact of uncertainty in a blood coagulation model. Math Med Biol 26:323–336

    PubMed  Google Scholar 

  129. Aleman MM, Walton BL, Byrnes JR, Wang JG, Heisler MJ, Machlus KR, Cooley BC, Wolberg AS (2013) Elevated prothrombin promotes venous, but not arterial, thrombosis in mice. Arterioscler Thromb Vasc Biol 33:1829–1836

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This review was supported by NIH HL46705 and by the Systems Biology program W911NF-10-1-0376. The authors would like to thank Drs. Bravo, Danforth, and Foley and M. Gissel for work on the mathematical models, and Drs. Baker, Bernstein, Francis, McLean, Neaton, Rivard, Rosendaal, Schneider, Tracy, and Undas for studies on their patient populations.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kathleen E. Brummel-Ziedins.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brummel-Ziedins, K.E., Everse, S.J., Mann, K.G. et al. Modeling thrombin generation: plasma composition based approach. J Thromb Thrombolysis 37, 32–44 (2014). https://doi.org/10.1007/s11239-013-1006-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-013-1006-9

Keywords

Navigation